Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coya Therapeutics (COYA) Restructuring Costs (2024 - 2025)

Coya Therapeutics' Restructuring Costs history spans 2 years, with the latest figure at $1.2 million for Q3 2025.

  • For Q3 2025, Restructuring Costs rose 9.78% year-over-year to $1.2 million; the TTM value through Sep 2025 reached $5.1 million, changed N/A, while the annual FY2024 figure was $4.6 million, 2.28% down from the prior year.
  • Restructuring Costs for Q3 2025 was $1.2 million at Coya Therapeutics, down from $1.5 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $1.5 million in Q2 2025 and bottomed at $991941.0 in Q4 2024.